ULS 欢迎您!
ULS 欢迎您!
> 产品中心 > 抑制剂 & 激动剂 > Protein Tyrosine Kinase/RTK > VEGFR

Brivanib

Cat. No.:YN440080

  • CAS No. :649735-46-6

    • 规格

      价格(RMB)

      库存

    • 产品资料
    • 生物活性
    • 参考文献
    • 产品名称: Brivanib
      CAS No.: 649735-46-6
      Chemical Name: (2R)-1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol
      Synonyms:布立尼布; BMS-540215
      分子量:370.38
      分子式:C₁₉H₁₉FN₄O₃
      SMILES:FC1=C(OC2=NC=NN3C2=C(C(OC[C@H](O)C)=C3)C)C=CC4=C1C=C(C)N4
      存储:Please store the product under the recommended conditions in theCertificate of Analysis.
      运输:Room temperature in continental US; may vary elsewhere.
      Select Batch:
      Purity: 98%
    • 产品描述: Brivanib (BMS-540215) 是一种 ATP 竞争性的VEGFR2抑制剂,IC50值为 25 nM;可以适度抑制 VEGFR-1 和 FGFR-1,对 VEGFR2 的选择性是对 PDGFR-β 的 240 倍。
      IC50和靶点: [{name:"VEGFR2:25 nM (IC50)"}]
      In Vitro:
      In Vivo:
      Clinical Trial:
      Solvent & Solubility:
    • Bhide, R.S., Cai, Z.W., Zhang, Y.Z., et al.Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitorJ. Med. Chem.49(7),2143-2146(2006)

      Nakamura, I., Zakharia, K., Banini, B.A., et al.Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signalingPLoS One9(4),e92273(2014)

    • 摩尔计算器
    • 稀释计算器
    摩尔浓度计算器方程 :
    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    计算

    质量 浓度 体积 分子量
    稀释计算器 :
    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
    • C1
      V1
      C2
      V2
    • 您最近查看的产品:
    相关产品


    ULS 的所有产品和服务仅用于科学研究,我们不为任何其他用途提供产品和服务(也不为任何个人提供产品和服务)Copyright © 2020-2021 ULS. All Rights Reserved. 备案号:粤ICP备2021013238号-1
    0.404189s